These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 26883634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Roles of RUNX in B Cell Immortalisation.
    West MJ, Farrell PJ.
    Adv Exp Med Biol; 2017; 962():283-298. PubMed ID: 28299664
    [Abstract] [Full Text] [Related]

  • 3. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
    Wood CD, Carvell T, Gunnell A, Ojeniyi OO, Osborne C, West MJ.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021904
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.
    Proc Natl Acad Sci U S A; 2015 Jan 13; 112(2):554-9. PubMed ID: 25540416
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E.
    J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
    Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E.
    Proc Natl Acad Sci U S A; 2011 Sep 06; 108(36):14902-7. PubMed ID: 21746931
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gélinas C, Walls D.
    J Virol; 2006 Aug 06; 80(16):8133-44. PubMed ID: 16873269
    [Abstract] [Full Text] [Related]

  • 8. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.
    Hosoi H, Niibori-Nambu A, Nah GSS, Bahirvani AG, Mok MMH, Sanda T, Kumar AP, Tenen DG, Ito Y, Sonoki T, Osato M.
    Gene; 2021 Mar 30; 774():145421. PubMed ID: 33444684
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
    Brady G, Whiteman HJ, Spender LC, Farrell PJ.
    J Virol; 2009 Jul 30; 83(13):6909-16. PubMed ID: 19403666
    [Abstract] [Full Text] [Related]

  • 10. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
    Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E.
    Proc Natl Acad Sci U S A; 2011 May 10; 108(19):7808-13. PubMed ID: 21518914
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L, Perricaudet M, Sergeant A, Manet E.
    J Virol; 1996 Sep 10; 70(9):5909-15. PubMed ID: 8709211
    [Abstract] [Full Text] [Related]

  • 12. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
    Zimber-Strobl U, Strobl LJ.
    Semin Cancer Biol; 2001 Dec 10; 11(6):423-34. PubMed ID: 11669604
    [Abstract] [Full Text] [Related]

  • 13. Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression.
    Paschos K, Bazot Q, Ho G, Parker GA, Lees J, Barton G, Allday MJ.
    Nucleic Acids Res; 2017 Mar 17; 45(5):2368-2383. PubMed ID: 27903901
    [Abstract] [Full Text] [Related]

  • 14. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
    Su C, Lu F, Soldan SS, Lamontagne RJ, Tang HY, Napoletani G, Farrell PJ, Tempera I, Kossenkov AV, Lieberman PM.
    PLoS Pathog; 2021 Aug 17; 17(8):e1009834. PubMed ID: 34352044
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
    Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, Narita Y, Zhang Z, Olson MR, Afzali B, Zhao B, Kazemian M.
    J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999023
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
    Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ.
    Oncogene; 2005 Mar 10; 24(11):1873-81. PubMed ID: 15688019
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9.
    Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dölken L, Zimmer R, Kempkes B.
    PLoS Pathog; 2013 Sep 10; 9(9):e1003638. PubMed ID: 24068939
    [Abstract] [Full Text] [Related]

  • 18. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
    Strobl LJ, Höfelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW, Zimber-Strobl U.
    Immunobiology; 1997 Dec 10; 198(1-3):299-306. PubMed ID: 9442401
    [Abstract] [Full Text] [Related]

  • 19. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    Sjöblom A, Jansson A, Yang W, Laín S, Nilsson T, Rymo L.
    J Gen Virol; 1995 Nov 10; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
    Bourillot PY, Waltzer L, Sergeant A, Manet E.
    J Gen Virol; 1998 Feb 10; 79 ( Pt 2)():363-70. PubMed ID: 9472621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.